ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial

Heart, Artery and Coronary DiseasesTherapy and Intervention

SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial

Lancet

Terkelsen CJ, Freeman P, Dahl JS, Thim T, Nørgaard BL, Mogensen NSB, Tang M, Eftekhari A, Povlsen JA, Poulsen SH, Pedersen L, Hjort J, Ellert J, Christiansen EH, Sørensen HT, Nissen H

doi: 10.1016/S0140-6736(25)00106-0

Heart, Artery and Coronary DiseasesTherapy and Intervention

Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves in Patients with Excessive Aortic Valve Cusp Calcification

Am Heart J

Tomii D, Alaour B, Heg D, Okuno T, Nakase M, Samim D, Praz F, Lanz J, Stortecky S, Reineke D, Windecker S, Pilgrim T

doi: 10.1016/j.ahj.2025.09.011

Heart, Artery and Coronary Diseases

Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial

Lancet

Nordanstig J, James S, Andersson M, Andersson M, Delle M, Engström J, Fransson T, Gillgren P, Hilbertson A, Hörer TM, Jacobsson E, Kragsterman B, Lindbäck J, Lindgren H, Ludwigs K, Mellander S, Nelzén O, Olin R, Sigvant B, Skoog P, Starck J, Tegler G, Thorbjørnsen K, Truedson M, Wahlgren CM, Wallinder J, Öjersjö A, Falkenberg M, SWEDEPAD trial investigators

doi: 10.1016/S0140-6736(25)01584-3

Heart, Artery and Coronary DiseasesTherapy and Intervention

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

J Am Coll Cardiol

Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Crouch J, Merhi W, Wai Sang SL, Kleiman NS, Petrossian G, Robinson NB, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick EM, Saito S, Oh JK, Jung Y, Reardon MJ, Low Risk Trial Investigators

doi: 10.1016/j.jacc.2025.03.004

Heart, Artery and Coronary DiseasesTherapy and Intervention

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial

Eur Heart J

Bleiziffer S, Leuschner F, Rudolph TK, Vonthein R, Meyer AL, Haeusler KG, Hofmann U, Gorski A, Hagendorff A, Kim WK, Baumgartner H, Borger MA, Choi YH, Cremer J, Falk V, Frey N, Hagl C, König IR, Landmesser U, Massberg S, Reichenspurner H, Renker M, Thiele H, Walther T, Ziegler A, Blankenberg S, Dreger H, Arif R, Unbehaun A, Seiffert M, DEDICATE Study Investigators

doi: 10.1093/eurheartj/ehaf519

Heart, Artery and Coronary Diseases

The Effects of Low-Dose Colchicine on the Progression of Aortic Valve Stenosis: Rationale, Design, and Baseline Characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial

Am Heart J

Mohammadnia N, Vestjens LTW, Craig NJ, Tijssen JGP, Knol RJJ, Lazarenko SV, Duffels MGJ, Focks JJ, Hemels MEW, Oving I, Schalkx HJ, Eikelboom JW, Cetinyurek-Yavuz A, Aarntzen EHJG, Dey D, Slomka PJ, Nijveldt R, Riksen NP, van Royen N, Honigberg MC, Dweck MR, Cornel JH, Messaoudi SE

doi: 10.1016/j.ahj.2025.07.010

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study

Lancet

Makkar RR, Thourani VH, Vahl TP, Yadav PK, McCabe JM, George I, Satler L, Chetcuti S, Daniels DV, Waggoner T, Whisenant B, Russo M, Summers M, Garcia S, Frisoli T, Ramana RK, Stinis C, Golwala H, Zahr F, Greenbaum A, Rovin J, Sanchez C, Szerlip M, Deeb GM, Amoroso N, Patel D, Fahy M, Ranard LS, Gupta A, Chakravarty T, Skaf S, Chuang M, Kodali SK, Figulla HR, Treede H, Baldus S, Pinto DS, Leon MB, ALIGN-AR Investigators

doi: 10.1016/S0140-6736(25)02215-9

Heart, Artery and Coronary DiseasesFurther Publications

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Clin Res Cardiol

Saad M, Seoudy H, Bramlage K, Bramlage P, Voran JC, Puehler T, Lutter G, Allali A, Landt M, Frank J, Bisht O, Salem M, Wienemann H, Adam M, Zeus T, Veulemans V, Bleiziffer S, Rudolph TK, Frank D

doi: 10.1007/s00392-025-02611-w

Heart, Artery and Coronary DiseasesTherapy and Intervention

Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial

Circulation

Lindman BR, Pibarot P, Schwartz A, Oldemeyer JB, Su YR, Goel K, Cohen DJ, Fearon WF, Babaliaros V, Daniels D, Chhatriwalla A, Suradi HS, Shah P, Szerlip M, Mack MJ, Dahle T, O'Neill WW, Davidson CJ, Makkar R, Sheth T, Depta J, DeVries JT, Southard J, Pop A, Sorajja P, Hahn RT, Zhao Y, Leon MB, Généreux P, EARLY TAVR Trial Executive Committee and Study Investigators

doi: 10.1161/CIRCULATIONAHA.125.074425

Related content

SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial

Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves in Patients with Excessive Aortic Valve Cusp Calcification

Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial

The Effects of Low-Dose Colchicine on the Progression of Aortic Valve Stenosis: Rationale, Design, and Baseline Characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR Trial